OOIR: Observatory of International Research

Papers

(The H4-Index of Seminars in Arthritis and Rheumatism is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	92
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	84
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	80
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	58
Response letter to the editor	50
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	49
Immunotherapy in cancer	47
The Autoantibody response in rheumatoid arthritis; what makes it unique?	44
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	43
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	41
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	40
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	40
Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis	40
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	38
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	38
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	38
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	37
mRNA vaccines in the rheumatologist's future	36
Exploring the association between adiposity, pain intensity, and effusion-synovitis in people with knee osteoarthritis: A cross-sectional study	34
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound	33
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation	33
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	32
Correspondence to ‘Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors’	31
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	31
Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts	30

OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	30
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	30
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	29
Is there room for precocious prevention in rheumatoid arthritis precision medicine? A temporal and stratified reframing in diagnostic and therapeutic pathway	28
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	28
Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis	28